COMMUNIQUÉS West-GlobeNewswire

Predictive Oncology Inc. (Formerly Precision Therapeutics) Names Amelia Warner, Pharm.D., RPh, as Interim Chief Operating Officer of Helomics
12/06/2019
MINNEAPOLIS, June 12, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: AIPT) (“Predictive Oncology” or the “Company”), a company focused on applying artificial intelligence to personalized medicine and drug [...]
Selecta Biosciences Presents Full Data from Phase 2 Trial of SEL-212 for Chronic Refractory Gout at EULAR 2019
12/06/2019
WATERTOWN, Mass., June 12, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune [...]
Soleno Therapeutics Announces Appointment of Veteran Industry Executive Birgitte Volck, M.D., Ph.D., to Board of Directors
12/06/2019
REDWOOD CITY, Calif., June 12, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
Crown Bioscience Announces Four New Preclinical NASH Models In Development
12/06/2019
- Reaffirms Commitment to NASH Drug Discovery - SAN DIEGO, June 12, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance [...]
HempAmericana CEO Addresses Company Expansion Following Strong Orders
12/06/2019
NEW YORK, June 12, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) CEO issues the following letter to Shareholders: Dear Valued Shareholder, As we begin to [...]
Tauri-Gum Successfully Penetrates New York City Metro Area Marketplace; Product Now Available at More than 250 Distinct Retail Stores and Locations
12/06/2019
NEW YORK, NY, June 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
Kiniksa Presents Preclinical Data on the GM-CSF Signaling Pathway in Temporal Arteries of GCA Patients at the Annual European Congress of Rheumatology
12/06/2019
- Preclinical data support rationale for targeting GM-CSF in GCA – - Mavrilimumab shows biological effect on genes relevant to GCA pathophysiology in ex vivo cultures of GCA arteries – HAMILTON, Bermuda, June 12, 2019 ( [...]
Strongbridge Biopharma plc to Present at the 2019 JMP Securities Life Sciences Conference
12/06/2019
DUBLIN, Ireland and TREVOSE, Pa., June 12, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
T2 Biosystems to Highlight its Products and Technology at Upcoming Medical Meetings
12/06/2019
LEXINGTON, Mass., June 12, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it will [...]
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended 30 April 2019
12/06/2019
Summit Therapeutics plc (‘Summit’, the ‘Company’ or the ‘Group’) Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended 30 April 2019 Oxford, UK, and Cambridge, MA, US, 12 [...]
Sorrento to Explore Potential Initial Public Offering of Scilex Holding Company
12/06/2019
SAN DIEGO, June 12, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Sorrento, Nasdaq: SRNE) today announced that it is exploring the possibility of an initial public offering of its majority-owned subsidiary, [...]
US Department of Defense Reports Final Results from Travelan® Shigellosis Challenge Study
12/06/2019
Key Highlights: Travelan ® shigellosis challenge studies in non-human primates successfully completed Travelan ® prevented clinical shigellosis (bacillary dysentery) in 75% of Travelan ® treated animals compared to [...]
Emerald Health Therapeutics Contracts for 1,200 Acres of Canadian Hemp Harvest, Reports Significant Progress on Factors Group Extraction Facility, and Forms US Hemp Subsidiary
12/06/2019
Emerald Aims to Harvest over 270,000 kg of Hemp in 2019, With the Potential to Produce Over 3,500 kg of Extracted CBD Oil VANCOUVER, British Columbia, June 12, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc [...]
Precision BioSciences Appoints Dario Scimeca as General Counsel
12/06/2019
DURHAM, N.C., June 12, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a genome editing company dedicated to improving life through the application of its proprietary ARCUS ® genome editing platform [...]
Biohit Oyj B-shares Subscribed with Stock Options I 2013
12/06/2019
Biohit Oyj Stock Exchange Release June 12, 2019 at 13.15 a.m. (EEST) A total number of 88,552 new Biohit Oyj B-shares have been subscribed for with stock options I 2013 between 12 February 2019 and 31 May 2019. These [...]
Affimed to Present Data on AFM13 at the 15th International Conference on Malignant Lymphoma in Lugano, Switzerland
12/06/2019
Heidelberg, Germany, June 12, 2019 – Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancer, announced today that two abstracts [...]
Philips announces exchange ratio for 2018 dividend in shares
12/06/2019
June 12, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that the exchange ratio for the dividend in shares for the year 2018 has been determined. The exchange ratio is 1 new [...]
TLC Presents New Pharmacokinetic and Toxicokinetic Data on TLC599 Following Intra-articular Injection in Dogs at EULAR 2019
12/06/2019
TLC599 showed locally sustained release profile up to 120 days, dose proportionality, minimal systemic exposure and potential for repeat dosing SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, June 12, 2019 (GLOBE [...]
Innate Pharma to present IPH4102 “TELLOMAK” clinical trial design and preclinical PTCL data at the 2019 ICML
12/06/2019
Multicohort, multi-center, international Phase II study to evaluate the efficacy and safety of IPH4102 in patients with advanced T-cell lymphoma is ongoing Sézary syndrome cohort of the TELLOMAK study is designed to [...]

Pages